Knockdown of cancer testis antigens modulates neural stem cell marker expression in glioblastoma tumor stem cells

Journal of Biomolecular Screening

Volumn 15, Issue 7, 2010, Pages 830-839

  Low, Jonathan ^a   Dowless, Michele ^a   Shiyanova, Tatiyana ^a   Rowlinson, Scott ^a   Ricci Vitiani, Lucia ^b   De Maria, Ruggero ^b   Pallini, Roberto ^c   Stancato, Louis ^a  

^a ELI LILLY AND COMPANY   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

cancer testis antigens; glioblastoma; high content; stem cells; subpopulation analysis

Indexed keywords

CANCER TESTIS ANTIGEN; CELL MARKER; PROTEIN; SHORT HAIRPIN RNA;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER SCREENING; CANCER STEM CELL; CELL DEATH; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; CELL TYPE; GENE EXPRESSION; GERM CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; METASTASIS; MULTIGENE FAMILY; NEURAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SHAPE; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; INTERMEDIATE FILAMENT PROTEINS; KI-67 ANTIGEN; MALE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 77956045847     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057110374983     Document Type: Article

References (27)

1. Low J., Huang S., Blosser W., Dowless M., Burch J., Neubauer B.,, et al. High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysis. Mol Cancer Ther 2008 ; 7: 2455-2463.
2. Low J., Stancato L., Lee J., Sutherland JJ: Prioritizing hits from phenotypic high-content screens. Curr Opin Drug Discov Dev 2008 ; 11: 338-345.
3. Whitehurst AW, Bodemann BO, Cardenas J., Ferguson D., Girard L., Peyton M.,, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007 ; 446: 815-819.
4. Diamandis P., Wildenhain J., Clarke ID, Sacher AG, Graham J., Bellows DS,, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol 2007 ; 3: 268-273.
5. Singh SK, Hawkins C., Clarke ID, Squire JA, Bayani J., Hide T.,, et al. Identification of human brain tumour initiating cells. Nature 2004 ; 432: 396-401.
6. Ricci-Vitiani L., Lombardi DG, Pilozzi E., Biffoni M., Todaro M., Peschle C.,, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007 ; 445: 111-1115.
7. Al-Hajj M., Wicha MS, Benito-Hernandez A., Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003 ; 100: 3983-3988.
8. Bao S., Wu Q., McLendon RE, Hao Y., Shi Q., Hjelmeland AB,, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006 ; 444: 756-760.
9. Costello RT, Mallet F., Gaugler B., Sainty D., Arnoulet C., Gastaut JA,, et al. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res 2000 ; 60: 4403-4411.
10. Pallini R., Ricci-Vitiani L., Banna GL, Signore M., Lombardi D., Todaro M.,, et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 2008 ; 14: 8205-8212.
11. Eramo A., Ricci-Vitiani L., Zeuner A., Pallini R., Lotti F., Sette G.,, et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006 ; 13: 1238-1241.
12. Postovit LM, Costa FF, Bischof JM, Seftor EA, Wen B., Seftor RE,, et al. The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells. J Cell Biochem 2007 ; 101: 908-917.
13. Hofmann O., Caballero OL, Stevenson BJ, Chen YT, Cohen T., Chua R.,, et al. Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A 2008 ; 105: 20422-20427.
14. Grizzi F., Franceschini B., Hamrick C., Frezza EE, Cobos E., Chiriva-Internati M.: Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med 2007 ; 5: 3.
15. Yuasa T., Okamoto K., Kawakami T., Mishina M., Ogawa O., Okada Y.: Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. J Urol 2001 ; 165: 1790-1794.
16. Cronwright G., Le Blanc K., Gotherstrom C., Darcy P., Ehnman M., Brodin B.: Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. Cancer Res 2005 ; 65: 2207-2215.
17. Gjerstorff MF, Harkness L., Kassem M., Frandsen U., Nielsen O., Lutterodt M.,, et al. Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation. Hum Reprod 2008 ; 23: 2194-2201.
18. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT: Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002 ; 188: 22-32.
19. Simpson AJ, Caballero OL, Jungbluth A., Chen YT, Old LJ: Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005 ; 5: 615-625.
20. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin NM,, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006 ; 9: 391-403.
21. Gunther HS, Schmidt NO, Phillips HS, Kemming D., Kharbanda S., Soriano R.,, et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008 ; 27: 2897-2909.
22. Nocjar C., Roth BL, Pehek EA: Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience 2002 ; 111: 163-176.
23. Liem RK, Yen SH, Salomon GD, Shelanski ML: Intermediate filaments in nervous tissues. J Cell Biol 1978 ; 79: 637-645.
24. Draberova E., Del Valle L., Gordon J., Markova V., Smejkalova B., Bertrand L.,, et al. Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J Neuropathol Exp Neurol 2008 ; 67: 341-354.
25. Scholzen T., Gerdes J.: The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000 ; 182: 311-322.
26. Huang L., Jiang T., Yuan F., Li GL, Cui Y., Liu EZ,, et al. Correlation of chromosomes 1p and 19q status and expressions of 06-methylguanine DNA methyltransferase (MGMT), p53 and Ki-67 in diffuse gliomas of World Health Organization (WHO) grades II and III: a clinicopathological study. Neuropathol Appl Neurobiol 2009 ; 35: 367-379.
27. Sell S.: Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004 ; 51: 1-28.